- Topic
- Product safety
- Regulator
- FDA
- Published
- 6 October 2026
- For
- Imports
- Where it applies
- United States
From the notice
The Food and Drug Administration (FDA) is publishing an order setting forth its final determination to exempt certain class II clinical toxicology test systems from premarket notification (510(k)) requirements, subject to certain limitations. This exemption from 510(k) requirements, subject to certain limitations, is immediately in effect for such devices. This exemption will decrease regulatory burdens on the medical device industry and will eliminate private costs and expenditures requiredThe full text is at the source
Olive tells you which of these hit your products.
Olive reads every change like these against your own products, codes and trade lanes, whether you import, export or both, and drafts the update to your compliance program for your approval. Nothing changes without you.
Olivra lists official notices for information only. It is not legal advice, and Olive is not a lawyer or a licensed customs broker. The official text at the source is what counts.
More from FDA
- Safety
Determination That Oxandrin (Oxandrolone) Tablets, 2.5 Milligrams and 10 Milligrams, Were
FDAUnited StatesImports - Safety
Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request
FDAUnited StatesImports - Safety
Determination PRALIDOXIME CHLORIDE (Autoinjector) (Pralidoxime Chloride) Solution, 600
FDAUnited StatesImports - Safety
Issuance of Priority Review Voucher; Rare Pediatric Disease Product; FAYUVI (rebisufligene
FDAUnited StatesImports